Mina Pastagia, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mina Pastagia, M.D.
Armata Pharmaceuticals, Inc. reported in an 8-K filed December 4, 2024 that Mina Pastagia, M.D. was terminated as Chief Medical Officer, effective November 13, 2024. Armata Pharmaceuticals, Inc. reported in an 8-K filed November 15, 2024 that Mina Pastagia, M.D. was terminated as Chief Medical Officer, effective November 13, 2024.
“On November 15, 2024, Armata Pharmaceuticals, Inc. (the "Company") disclosed that it had reached an agreement with Mina Pastagia, M.D. ("Dr. Pastagia"), the Company's Chief Medical Officer, pursuant to which Dr. Pastagia's employment had concluded effective as of November 13, 2024 (the "Termination Date").”
“On November 13, 2024 (the "Termination Date"), the Company terminated the employment of Mina Pastagia, M.D. ("Dr. Pastagia"), Chief Medical Officer of the Company, effective as of the close of business on the Termination Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2023-01-01–2024-11-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.